The link between obstructive sleep apnea and heart failure: Underappreciated opportunity for treatment

Current Heart Failure Reports

Volumn 3, Issue 4, 2006, Pages 183-188

  Naughton, Matthew T ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; SLEEP APNEA, OBSTRUCTIVE;

EID: 34250853141     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-006-0020-z     Document Type: Review

References (54)

1. Shanoudy H, Soliman A, Raggi P, et al.: Prevalence of patent ovale foramen and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 1998, 113:91-96.
2. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
3. Kenchaiah S, Evans JC, Levy D, et al.: Obesity and the risk of heart failure. N Engl J Med 2002, 347:305-313.
4. Solin P, Roebuck T, Johns DP, et al.: Peripheral and central ventilatory responses in central sleep apnea with and without heart failure. Am J Respir Crit Care Med 2000, 162:2194-2200.
5. Solin P, Bergin P, Richardson M, et al.: Influence of pulmonary capillary wedge pressure on CSA in heart failure. Circulation 1999, 99:1574-1579.
6. Brooks D, Horner RL, Kozar LF, et al.: Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997, 99:106-109.
7. Shahar E, Whitney CW, Redline S, et al.: Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163:19-25.
8. Worsnop CJ, Naughton MT, Barter CE, et al.: The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998, 157:111-115.
9. Nieto FJ, Young TB, Lind BK, et al.: Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000, 283:1829-1836.
10. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
11. Logan AG, Perlikowski SM, Mente A, et al.: High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001, 19:2271-2277.
12. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al.: Ambulatory blood pressure following therapeutic and subtherapeutic nasal CPAP for OSA: A randomised controlled parallel trial. Lancet 2002, 359: 204-210.
13. Becker HF, Jerrentrup A, Ploch T, et al.: Effect of nasal CPAP treatment on blood pressure in patients with OSA. Circulation 2003, 107:68-73.
14. Chobanian AV, Bakris GL, Black HR, et al.: Joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003, 42:1206-1252. This paper accepts OSA as an important reversible cause of hypertension.
15. Mooe T, Franklin KA, Wiklund U, et al.: Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 2000, 117:1597-1602.
16. Koehler U, Trautmann M, Trautmann R, et al.: Does sleep apnea increase the risk of myocardial infarct during sleep? Z Kardiol 1999, 88:410-417.
17. Aboyans V, Cassat C, Lacroix P, et al.: Is the morning peak of acute myocardial infarction's onset due to sleep-related breathing disorders? A prospective study. Cardiology 2000, 94:188-192.
18. Hung J, Whitford EG, Parsons RW, Hillman DR: Association of sleep apnea with myocardial infarction in men. Lancet 1990, 336:261-264.
19. Peker Y, Hedner J, Norum J, et al.: Increased incidence of cardiovascular disease in middle-aged men with OSA: A 7-year follow-up. Am J Respir Crit Care Med 2002, 166:159-165.
20. Peled N, Abinader EG, Pillar G, et al.: Nocturnal ischemic events in patients with OSA syndrome and ischemic heart disease: Effects of continuous positive air pressure. J Am Coll Cardiol 1999, 34:1744-1749.
21. Franklin KA, Nilsson JB, Sahlin C, Naslund U: Sleep apnea in nocturnal angina. Lancet 1995, 345:1085-1087.
22. Lavie L, Vishnevsky A, Lavie P: Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004, 27:123-128.
23. Ip MS, Tse HF, Lam B, et al.: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004, 169:348-353.
24. Tazaki T, Minoguchi K, Yokoe T, et al.: Increased levels of and activity of metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004, 170:1354-1359.
25. Kato M, Roberts-Thompson P, Phillips BG, et al.: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000, 102:2607-2610.
26. Curry BD, Bain JL, Yan JG, et al.: Vibration injury damages arterial endothelial cells. Muscle Nerve 2002, 25:527-534.
27. Drage LF, Bortolotto LA, Lorenzi MC, et al.: Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:613-618.
28. Chan J, Sanderson J, Chan W, et al.: Prevalence of sleepdisordered breathing in diastolic heart failure. Chest 1997, 111:1488-1493.
29. Sin DD, Fitzgerald F, Parker JD, et al.: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160:1101-1106.
30. Laaban JP, Pascal-Sebaoun S, Bloch E, et al.: Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002, 122:1133-1238.
31. Alchanatasis M, Tourkohoriti G, Kosmas EN, et al.: Evidence for left ventricular dysfunction in patients with obstructive sleep apnea syndrome. Eur Respir J 2002, 20:1239-1245.
32. Fung JW, Li TS, Choy DK, et al.: Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002, 121:422-429.
33. Amin RS, Kimball TR, Bean JA, et al.: Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:1395-1399.
34. Fletcher EC, Proctor M, Yu J, et al.: Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med 1999, 160:1688-1696.
35. Parker JD, Brooks D, Kozar LF, et al.: Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 1999, 160:1888-1896.
36. Scharf SM, Bianco JA, Tow DE, et al.: The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary artery disease. Circulation 1981, 63:871-875.
37. Serizawa T, Vogel M, Apstein CS, Grossman W: Comparison of acute alterations in left ventricular relaxation in left ventricular relaxation and diastolic chamber stiffness induced by hypoxia and ischemia. J Clin Invest 1981, 68:91-102.
38. Guardiola J, Yu J, Hasan N, Fletcher EC: Evening and morning blood gases in patients with OSA. Sleep Med 2004, 5:489-493.
39. Buda AJ, Schroeder JS, Guilleminault C: Abnormalities of pulmonary artery wedge pressures in sleep-induced apnea. Int J Cardiol 1981, 1:67-74.
40. Cloward TV, Walker JM, Farney RJ, Anderson JL: Left ventricular hypertrophy is a common echocardiographic abnormality in severe OSA and reverses with CPAP. Chest 2003, 124:594-601.
41. Malone S, Liu PP, Holloway R, et al.: OSA in patients with idiopathic dilated cardiomyopathy: Effects of CPAP. Lancet 1991, 38:1480-1484.
42. Krieger J, Grucker D, Sforza E, et al.: LVEF in OSA. Effect of long term treatment with nasal continuous positive airway pressure. Chest 1991, 100:917-921.
43. Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of CPAP in patients with CHF and OSA. N Engl J Med 2003, 348:1233-1241. This study confirmed prior before and after studies with a randomized, controlled trial that CPAP augments cardiac function and reduces blood pressure and LV chamber size in patients with CHF and OSA over 1 month.
44. Mansfield D, Gollogly NC, Bergin P, et al.: Controlled trial of CPAP in OSA and heart failure. Am J Respir Crit Care Med 2004, 169:361-366. This study published also confirmed CPAP augmented cardiac function, reduced sympathetic activity and improved quality of life in CHF patients with OSA over 3 months.
45. Artz M, Harth M, Blumberg F, Pfeifer M: Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in congestive heart failure. Am J Respir Crit Care Med 2004, 169:A747.
46. Robinson GV, Stradling JR, Davies RJ, Roberts IS: Post mortem diagnosis of fatal obstructive sleep apnea. Histopathology 2004, 45:542.
47. Lindberg E, Janson C, Svardsudd K, et al.: Increased mortality among sleepy snorers: A prospective population study. Thorax 1998, 53:631-637.
48. Veale D, Chailleux E, Hoorelbeke-Ramon A, et al.: Mortality of sleep apnea patients treated by CPAP registered with ANTIADIR. Eur Resp J 2000, 15:326-331.
49. Marti G, Sampol G, Munoz X, et al.: Mortality in severe sleep apnea/ hypopnoea syndrome patients: Impact of treatment. Eur Resp J 2002, 20:1511-1518.
50. Roebuck T, Solin P, Kaye DM, et al.: Increased long term mortality due to sleep apnea in heart failure is yet to be proven. Eur Respir J 2004, 23:735-740.
51. Gami AS, Howard DE, Olson EJ, Somers VK: Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352:1206-1214.
52. Bersten AD, Holt AW, Vedig A, et al.: Treatment of severe cardiogenic pulmonary edema with CPAP. N Engl J Med 1991, 325:1825-1830.
53. Kaye DM, Mansfield D, Aggarwal A, et al.: Acute effects of CPAP on cardiac sympathetic tone in CHF. Circulation 2001, 103:2336-2338.
54. Naughton MT: Effect of CPAP on intrathoracic and left ventricular transmural pressure in CHF. Circulation 1995, 91:1725-1731.